Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.6% – Should You Sell?

Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were down 1.6% on Thursday . The stock traded as low as $9.41 and last traded at $9.84. Approximately 354,980 shares changed hands during trading, a decline of 75% from the average daily volume of 1,403,603 shares. The stock had previously closed at $10.00.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on Tonix Pharmaceuticals in a research report on Monday, February 10th. They set a “sell” rating for the company.

Tonix Pharmaceuticals Trading Down 5.2 %

The company has a current ratio of 3.33, a quick ratio of 2.81 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $17.15 million, a P/E ratio of 0.00 and a beta of 2.07. The firm has a 50-day moving average of $27.92 and a two-hundred day moving average of $23.43.

Hedge Funds Weigh In On Tonix Pharmaceuticals

Large investors have recently bought and sold shares of the company. Commonwealth Equity Services LLC bought a new position in Tonix Pharmaceuticals in the fourth quarter valued at about $40,000. Two Sigma Investments LP bought a new position in Tonix Pharmaceuticals in the fourth quarter valued at about $66,000. PFG Investments LLC bought a new position in Tonix Pharmaceuticals in the fourth quarter valued at about $72,000. Northern Trust Corp bought a new position in Tonix Pharmaceuticals in the fourth quarter valued at about $162,000. Finally, Point72 Asset Management L.P. bought a new position in Tonix Pharmaceuticals in the fourth quarter valued at about $526,000. 82.26% of the stock is currently owned by institutional investors.

Tonix Pharmaceuticals Company Profile

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.